‘Cutting red tape,’ mental health and primary care on the health docket this fall
Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers are priorities.
Liberals need to get it together on pharmacare
A strong government instills confidence in the country’s people and its businesses. This government’s waffling on pharmacare does none of that.
Canada at risk of collateral damage in U.S. drug pricing war
A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
A broken promise, yet again: Why Canada needs national pharmacare now
As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country as wealthy and compassionate as Canada claims to be, this is cruel.
Saskatchewan, Newfoundland, Nunavut, and Northwest Territories all open to pharmacare talks, but say they’re not taking place
The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister Marjorie Michel’s office says it will honour the four existing deals, but is not promising to negotiate others.
What the early pharmacare rollout is teaching us—and why governments must listen
Canada must move beyond assuming that a single-payer model alone can solve systemic gaps in access, and design a truly universal system that works alongside private plans.
A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes
Guideline changes became necessary after Justin Trudeau’s government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
Health sector looks to pharmacare and more to help address financial hit of U.S. trade war
Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
Time to make more pharmacare deals after election stalled momentum
Before the campaign, Ottawa secured agreements with only four jurisdictions: Manitoba, British Columbia, Yukon, and Prince Edward Island.
Liberals to push ahead with pharmacare, but program’s fate under Conservatives is unclear
Health Minister Kamal Khera highlighted Yukon signing onto the pharmacare deal since Mark Carney became prime minister, saying the Liberal government ‘will continue to make sure we deliver for Canadians.’
